are as follows; Operating Performance 1. Revenue Unit: Million Baht Information of period Consolidated Separate Value Change Value Change Q2.2019 Q2.2018 Amount % Q2.2019 Q2.2018 Amount % Revenue from
had total revenue of 298.22 million baht, a decrease of 48.96 million baht or 14.10 percent, with the total net loss of 34.94 million baht or decreased 94.98 percent and net loss owners of the parent
, 2019 Financial Statement Consolidate financial statement % revenue from sales Q4/2019 Q4/2018 increase(decrease) Q4/2019 Q4/2018 Revenues from sales 218.50 175.66 42.84 24.39% 100.00% 100.00% Cost of
strong performance in 4Q19 and 2019 driven mainly by gains on sales of assets or investments as well as higher revenue and profits from new business investment as aforementioned. The Company has already
sugar and recognized the revenue from sugar sale in second quarter. However, last year 2016, the company exported raw sugar and recognized the revenue in third quarter. As a result, the total revenue from
subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st
accounting from the disposal of assets that will help developing overall image of the financial statements. Moreover, the Company will gain revenue as the increased cash flows of 70.00 million Baht from sale
the Q2/2017, the company and its subsidiaries have the total revenue from sales in amount of Baht 3,199.0 million which is increasing from the 2016 at equivalence of Baht 379.4 million, about 13%. These
in the Q3/2017, the company and its subsidiaries have the total revenue from sales in amount of Baht 3,282.3 million which is increasing from the 2016 at equivalence of Baht 453.3 million, about 16